Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-II Supplementation for Joint Discomfort in Healthy Subjects
NCT05212259Unknown
- Sponsor
- Vedic Lifesciences
- Start
- Oct 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in arthralgia (5 arms), sponsored by Vedic Lifesciences. Primary endpoint: Range of Motion (active flexion and extension) at Day 180. Status: unknown.
02
Conditions
arthralgia
Beyond the preview
Go deeper on NCT05212259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05212259.